Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease
G. Van Assche, F. Baert, S. VermeireVolume:
35
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1365-2036.2012.05023.x
File:
PDF, 52 KB
english, 2012